Promoter holding
64.27%
CA
Chakrapani Ayurveda Private Limited - Due diligence report
A 360° intelligence report on Chakrapani Ayurveda Private Limited: trust score, financial health, credit view, compliance, directors, growth…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Chakrapani Ayurveda Private Limited — 360° Intelligence Report
Generated from MCA filings & public records81/100
Trust Score
Low Risk
Chakrapani Ayurveda Private Limited is assessed as Low Risk with a Trust Score of 81/100. Chakrapani Ayurveda Private Limited is an active private limited indian non-government company incorporated in 2008, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 26 Aug 2026 from the latest processed filings. Chakrapani Ayurveda Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2020 - filings overdue.
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ATUL KOTECHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAY SHREE KOTECHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 17+ years.
Distress signals & risk flags
Profit declined two years in a row.
Statutory filings appear overdue.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 6 events31 Dec 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
29 Dec 2017
Director ceased
RAJESH KUMAR KOTECHA
28 Dec 2017
Director appointed
JAY SHREE KOTECHA (Director)
11 Nov 2008
Incorporated
Registered with Roc Jaipur
Director appointed
ATUL KOTECHA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| D- Health N Fame Marketing Private Limited | U51909ML2002PTC006869 | Shillong, Meghalaya, India |
| Vardman Biochem Private Limited | U24246DL2006PTC144393 | Delhi, Delhi, India |
| Cenozoic Remedies Private Limited | U85126UP2004PTC029173 | Kanpur, Uttar Pradesh, India |
| G.K.Bio Sciences (India) Private Limited | U01409TG2010PTC069260 | Hyderabad, Telangana, India |
| Atharva Herbals Private Limited | U24233MH2002PTC135183 | Vasai, Maharashtra, India |
| Devam Ayurveda Private Limited | U24233UP2006PTC032323 | Lucknow, Uttar Pradesh, India |
| Mimansha Marketing Private Limited | U52100UP2011PTC047831 | Lucknow, Uttar Pradesh, India |
| Ayurwin Pharma | U24232KA2011PTC061041 | Bangalore, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Chakrapani Ayurveda Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Chakrapani Ayurveda Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Chakrapani Ayurveda Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Chakrapani Ayurveda Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Chakrapani Ayurveda Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Chakrapani Ayurveda Private Limited an active company?
Chakrapani Ayurveda Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Chakrapani Ayurveda Private Limited financially healthy?
Chakrapani Ayurveda Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Chakrapani Ayurveda Private Limited?
Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Chakrapani Ayurveda Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Chakrapani Ayurveda Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Chakrapani Ayurveda Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Chakrapani Ayurveda Private Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
